After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ACAD belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Acadia Pharmaceuticals Inc is $2.41B. A total of 0.91 million shares were traded on the day, compared to an average of 1.73M shares.
In the most recent transaction, Schneyer Mark C. sold 9,733 shares of ACAD for 15.28 per share on Aug 19 ’24. After the transaction, the EVP, CHIEF FINANCIAL OFFICER now owns 43,735 company shares. In a previous transaction on Aug 19 ’24, Teehan Brendan sold 9,534 shares at 15.28 per share. ACAD shares that EVP, COO, HEAD OF COMMERCIAL owns now total 52,177.
Among the insiders who sold shares, DAVIS STEPHEN disposed of 31,747 shares on Aug 19 ’24 at a per-share price of $15.28. This resulted in the CEO holding 186,555 shares of ACAD after the transaction. In another insider transaction, Schneyer Mark C. sold 975 shares at $14.79 per share on Jun 10 ’24. Company shares held by the EVP, CHIEF FINANCIAL OFFICER now total 34,564.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ACAD has a high of $32.59 and a low of $14.44.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ACAD’s latest balance sheet shows that the firm has $520.71M in Cash & Short Term Investments as of fiscal 2021. There were $64.43M in debt and $96.07M in liabilities at the time. Its Book Value Per Share was $3.12, while its Total Shareholder’s Equity was $540.89M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACAD is Buy with a score of 4.20.